Back to results
US 9,867,864 B2Granted
Use of somatostatin analogs in control of hypoglycemia
AssigneeNovartis AG
InventorHerbert Schmid
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of a Somatostatin (SRIF) analog which has a high binding affinity to human SSTR1,2,3,5, or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical composition for the control of hypoglycemia.
Claims1
A method of treating post-prandial reactive hypoglycemia consisting of administering to a patient in need thereof pasireotide or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.